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Construction of a Diverse Set of Terpenoid Decalin Subunits from 
a Common Enantiomerically Pure Scaffold Obtained by a 
Biomimetic Cationic Cyclization 
Raquel Fontaneda, Francisco J. Fañanás* and Félix Rodríguez* 
An unprecedented biomimetic cationic cyclization reaction of an 
alkyne-containing geraniol-derived epoxide is used for the 
stereoselective synthesis of a novel enantiomerically pure scaffold 
that is easily transformed into a set of structurally diverse decalin 
derivatives with potential application in the synthesis of targeted 
natural products and/or natural-product-inspired new molecules. 
Enantiomeric scaffolding is a concept introduced by L. S. 
Liebeskind to describe an alternative strategic and structured 
approach to the enantiocontrolled construction of different 
complex molecules from a simple precursor.1 Thus, an 
enantiomeric scaffold could be defined as a conceptually simple 
core molecule of high enantiopurity that bears some tactically 
versatile functionalities that enable its elaboration in ways that 
allow access to diverse families of important molecules. To find 
application as a platform for complex molecule construction, a 
scaffold molecule should comprise some key features. First, it 
should contain a chiral structure overlapping many common 
motifs in target molecules. Second, it should be easily available 
in a scalable way in a minimum number of synthetic steps. And 
finally, it should contain some additional functionality that 
permits subsequent elaborations. Different scaffolding 
approaches have been developed in recent years by several 
research groups and some typical examples are shown in Figure 
1a.1,2 Although these platforms have been used for the 
construction of different natural products (and natural-product-
like molecules), the enantiomeric scaffolding concept has not 
been fully developed in the context of terpene synthesis.3 
Under these circumstances, we identify the decalin derivative 1 
as a broadly-applicable template for the synthesis of diverse 
terpenes and derivatives (Figure 1b). More precisely, we 
thought that the left-hand ring of this enantiomerically pure 
scaffold could be easily transformed into a variety of different 
skeletons 2-10. It should be noted that thousands of terpenoid 
natural products contain in their structure some of the 
structural motifs of the left-hand ring of products 2-10. In the 
other hand, the alkenyl bromide moiety of the right-hand ring 
of 1 seemed a perfect functionality for further elaboration and 
construction of target molecules.4 
 
Figure 1 Some examples of enantiomerically pure scaffolds and our proposal. 
In addition, we thought that both enantiomers of scaffold 1 
could be easily available at large scale. All these features make 
decalin 1 an ideal enantiomerically pure platform for the 
synthesis of a great variety of terpenes and related molecules. 
The synthesis of this enantiomerically pure scaffold along with 
initial studies on its transformation into key structural motifs as 
a demonstration of its synthetic utility are herein presented. 
Our investigation began with the design of an efficient synthetic 
sequence that allow the preparation of decalin 1 in an 
enantioselective way. As shown in Scheme 1, this compound 
could be easily prepared from commercially available geranyl 
acetate (11).5 Selective asymmetric dihydroxylation of the gem-
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dimethyl substituted alkene of this molecule using AD-mix- 
followed by selective mesylation of the secondary alcohol and 
subsequent intramolecular nucleophilic substitution led to the 
corresponding epoxide. The so-formed allylic alcohol was 
efficiently transformed into the bromide (+)-12 that was 
coupled with a propargyl-lithium derivative to generate, after 
appropriate work-up, the enyne containing epoxide (+)-13. All 
this sequence could be performed at multigram scale as 
demonstrated by the synthesis of 4.8 grams of (+)-13 in one 
batch (51% overall yield from geranyl acetate). 
 
Scheme 1 Reagents and conditions: a) ADmix-, MeSO2NH2, tBuOH, H2O, 0 
ºC, 20 h; b) MsCl, pyridine, CH2Cl2, 0 ºC, 3 h, then K2CO3, MeOH, 0 ºC to RT, 12 
h; c) MsCl, Et3N, CH2Cl2, 0 ºC, 30 min, then LiBr, THF, 0 ºC, 2,5 h; d) TMSCCCH3, 
nBuLi, THF, 60 ºC, 1 h; then (+)-12, 0 ºC, 2.5 h; then K2CO3, MeOH, RT, 16 h; 
e) AlBr3 (0.33 equiv), CH2Br2 (0.1M), 40 ºC, 1 h. 
Taking advantage of our recent studies on cationic cyclization 
reactions,4,6 we considered that a biomimetic cationic 
cyclization reaction of (+)-13 initiated by the ring opening of the 
epoxide and performed in dibromomethane (as solvent and 
source of bromide) could render our desired enantiomerically 
pure scaffold 1. After some experimentation, we found that 
aluminium bromide was an appropriate promoter for this 
process (see the ESI for experiments performed to demonstrate 
that the bromine comes from the solvent). Thus, when epoxide 
(+)-13 was reacted with aluminium bromide (0.33 equiv) in 
dibromomethane (0.1 M) at 40 ºC, decalin ()-1 could be 
isolated in high overall yield (42% from geranyl acetate) and 
excellent enantiomeric excess (97%). The arrangement shown 
in I could explain the formation of the observed isomer ()-1. 
Remarkably, 5.5 grams of decalin ()-1 could be prepared in one 
batch without problems. It is important to note that the 
enantiomer ()-1 could be easily obtained by using AD-mix- in 
the first step of the sequence. The overall yield and 
enantiopurity was similar to that observed for ()-1. 
At this point, the cyclization of enyne-containing epoxide (+)-13 
to decalin ()-1 deserves some comment. Thus, it should be 
noted that in the context of biomimetic cyclizations,7 reactions 
with starting materials containing an epoxide as initiating group 
in combination with different terminating groups are well 
documented.8 Also, reactions with starting materials combining 
an alkyne as terminating group and different initiating groups 
have been widely reported.9 But surprisingly, biomimetic 
cyclization reactions of substrates such as (+)-13 with the 
particular combination of an epoxide as initiating group and an 
alkyne as terminating group have been scarcely reported and 
they are limited to examples where the alkyne acts as a masked 
ketone.10 It seems that, despite its apparent potential, this gap 
in the context of biomimetic cyclization reactions have passed 
somewhat unnoticed by the synthetic community because no 
progresses have been reported since those early works 
published long time ago. Thus, we are herein reporting the first 
example of a biomimetic cationic cyclization reaction of an 
epoxide-containing enyne derivative to get a functionalized 
bicyclic alkenyl bromide.11 It should be noted that the use of an 
epoxide as initiating group is particularly interesting because it 
allows the synthesis of enantiomerically pure cyclic compounds. 
This fact supposes a tremendous advantage over our previously 
developed biomimetic cyclization reactions with alkenes as 
initiating groups where only racemic products could be 
obtained.4,6 The use of the alkyne as terminating group in this 
new biomimetic cyclization is also highly beneficial because it 
allows getting a product with a new functionality, an alkenyl 
bromide, that may be easily elaborated.12 Other traditional 
biomimetic cyclization reactions with epoxides as initiating 
groups but with conventional terminating groups, such as 
alkenes or arenes, lead to final products synthetically less 
versatile than the alkenyl bromide. Hence, the new biomimetic 
cyclization reaction exemplified in the transformation of 
epoxide-containing enyne (+)-13 into decalin ()-1 seems to be 
a powerful synthetic tool. 
 
Scheme 2 Reagents and conditions: a) PCC, CH2Cl2, RT, 2 h; b) PCl5, toluene, 
25 ºC, 1h; c) (i) TsNHNH2, MeOH, RT, 18 h; (ii) catecholborane, CH2Cl2, RT, 3 h; 
(iii) NaOAc, MeOH, 60 ºC, 16 h.  
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With a substantial quantity of enantiomerically pure scaffold 
()-1 in hand, we turned our attention to demonstrate its utility 
as precursor of a diverse set of frameworks with ubiquitous 
presence in terpenoids and related molecules. Some simple 
initial transformations of decalin ()-1 to get interesting new 
chemical entities are shown in Scheme 2a. Thus, oxidation of 
the alcohol under conventional conditions delivered the ketone 
()-2. Otherwise, treatment of ()-1 with phosphorus 
pentachloride (PCl5) induced a ring contraction process to get 
the new enantiomerically pure bicyclic product ()-3. 
Furthermore, the deoxygenated decalin derivative ()-4 could 
be efficiently obtained by transformation of ketone ()-3 into 
the corresponding tosylhydrazone derivative and subsequent 
reduction with catecholborane. Remarkably, all these synthetic 
transformations were chemoselective, and thus, the alkenyl 
bromide functionality remained always intact. This is an 
important point because this is the functionality that allows 
further elaboration and construction of target molecules.12 In 
this sense, it should be noted that the synthesis of compound 
()-4 supposes a formal asymmetric synthesis of the natural 
product ()-pallescensin A and demonstrates that the alkenyl 
bromide moiety can be easily transformed.4a Not only ()-
pallescensin A but other natural products such as (+)-retigeranic 
acid, ()-myrrhanol A, (+)-3-oxotauranin, and ()-syn-copalol 
could be available from products ()-1, ()-2, ()-3 and ()-4 
(Scheme 2b). 
The next challenge was the introduction of additional 
functionality around the decalin core (Scheme 3a). Selective 
hydroxylation of just one of the methyl substituents was easily 
achieved from ketone ()-2 through a sequence involving the 
initial formation of the corresponding oxime derivative. 
Subsequent palladium-catalysed selective C-H acetoxylation 
followed by hydrolysis gave rise to the new enantiomerically 
pure hydroxy ketone ()-5 (Scheme 3a). Interestingly, the 
bicyclic core of the natural product ()-rostratone possesses an 
arrangement similar to that of hydroxy ketone ()-5 (Scheme 
3b). Additionally, this ketone ()-5 could be selectively reduced 
to give the new diols ()-6 or ()-7. More precisely, conventional 
reduction of ()-5 with sodium borohydride exclusively led to 
()-6 (the new hydroxyl-group in an equatorial position). 
However, the diastereoisomeric diol ()-7 was selectively 
obtained when ketone ()-5 was reacted with L-selectride (the 
new hydroxyl-group in an axial position). It should be noted that 
both diastereoisomeric structural arrangements can be found in 
natural products. For example, while ()-aphidicolin has a 
structure similar to ()-7, the core assembly of lagochiline 
resembles that of ()-6 (Scheme 3b). The structure of many 
other terpenes is characterized by a decalin skeleton decorated 
with a carboxylic acid. An example of this type of natural 
products is xiamicyn A (Scheme 3b). This core was easily 
synthesized from ()-6 by reaction with TEMPO to get the 
corresponding aldehyde that was further oxidized to get the 
carboxylic acid derived scaffold ()-8 (Scheme 3a). Again, all 
these synthetic transformations did not affect the alkenyl 
bromide moiety and thus, this functionality could be used for 
the introduction of the additional decoration usually found 
around the decalin core of natural products.12 
 
Scheme 3 Reagents and conditions: a) (i) NH2OH·HCl, NaOAc, MeOH, H2O, 85 
ºC, 2 h; (ii) Pd(OAc)2 (15 mol%), PhI(OAc)2, AcOH, Ac2O, 65 ºC, 6 h; (iii) K2CO3, 
MeOH, RT, 18 h; then NaHSO3, MeOH, H2O, 40 ºC, 36h; b) NaBH4, MeOH, RT, 
2 h; c) L-Selectride, THF, 30 ºC, 22 h; then H2O2, NaOH (aq, 4M), THF, RT, 1 
h; d) TEMPO (15 mol%), PhI(OAc)2, CH2Cl2, 5h, RT; then NaClO2, NaH2PO4, 2-
methyl-2-butene, tBuOH, H2O, RT, 30 min.  
In order to access additional scaffolds with potential application 
in the synthesis of terpenoids, the ketone functionality of 
compound ()-5 was fully reduced to get the alcohol ()-9 in 
high overall yield (80%; Scheme 4a). Interestingly, this scaffold 
is widespread in natural products being (+)-abietinol a 
representative example (Scheme 4b). 
 
 
Scheme 4 Reagents and conditions: a) (i) TsNHNH2, MeOH, RT, 16 h; (ii) 
catecholborane, CH2Cl2, RT, 3 h; (iii) NaOAc, MeOH, 60 ºC, 16 h; b) Jones’ 
reagent, acetone, RT, 5 h. 
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Similar natural products containing a carboxylic acid instead of 
an alcohol are also prevalent in Nature (i.e. ()-trans-ozic acid; 
Scheme 4b). This motif was easily obtained from alcohol ()-9 
by a conventional oxidation reaction. Thus, carboxylic acid ()-
10 was isolated in 95% yield as single enantiomer. 
In summary, we have developed an unprecedented cationic 
cyclization reaction of a substrate containing an epoxide as 
initiating group and an alkyne as terminating functionality. This 
reaction closes a gap in the context of biomimetic cyclizations 
and we anticipate that it will find wide utility in the field of 
natural product total synthesis. Particularly, we have applied 
this new reaction to the synthesis of a decalin derivative that 
comprises all the features of an enantiomeric scaffold: its 
structure overlaps many common motifs in target molecules, 
both enantiomers are easily available in a scalable way in a 
minimum number of synthetic steps, and it contains additional 
functionalities for subsequent elaborations. More precisely, the 
enantiomerically pure decalin derivative here presented 
contains an alcohol in one of the rings and an alkenyl bromide 
in the other one. Interestingly, these two functionalities could 
be orthogonally transformed.  
 
Figure 2 Summary of the enantiomeric scaffolding herein presented. 
Thus, by one hand, the cycle containing the alcohol could be 
easily transformed into a variety of new enantiomerically pure 
scaffolds widespread found in terpenoids (Figure 2). In the other 
hand, the synthetic versatility of the alkenyl bromide 
functionality offers the opportunity for further elaboration of 
the decalin core as demonstrated with the formal synthesis of 
()-pallescensin A.12 Noteworthy, this work constitutes one of 
the very few examples where the concept of enantiomeric 
scaffolding is disclosed in the context of terpene synthesis. 
However, not only target products, but also libraries of 
enantiomerically pure natural-product-inspired molecules for 
drug discovery could be easily available from the new molecules 
herein presented. 
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